Sudeep Pharma Share Price
1344.40+51.60 (+3.99%)
+73.66% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 24% | 14% | 28% |
| - | 39% | 41% | 26% |
| - | - | - | - |
| 33% | 34% | 35% | 25% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
LUPIN
MANKIND
DRREDDY
AUROPHARMA
SUDEEPPHRM
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,899 | ₹456833 Cr | 37.77 | 12.07 | 62.82 | ₹11479 Cr |
| 9,100 | ₹245426 Cr | 83.91 | 34.04 | 128.41 | ₹2568 Cr |
| 4,857 | ₹187320 Cr | 85.89 | 16.72 | 97.06 | ₹2163 Cr |
| 1,120 | ₹113217 Cr | 25.09 | 9.42 | 62.53 | ₹5040 Cr |
| 1,385 | ₹112212 Cr | 33.29 | 9.77 | 57.87 | ₹3879 Cr |
| 1,840 | ₹101155 Cr | 92.52 | 6.8 | 29.25 | ₹889 Cr |
| 2,110 | ₹97626 Cr | 17.66 | 30.95 | 154.36 | ₹5333 Cr |
| 2,327.9 | ₹96859 Cr | 47.42 | 13.75 | 71.08 | ₹1913 Cr |
| 1,151 | ₹96406 Cr | 29.92 | 5.32 | 63.99 | ₹4196 Cr |
| 1,653.1 | ₹93614 Cr | 25.22 | 17.95 | 96.84 | ₹3505 Cr |
| 1,329.3 | ₹14631 Cr | 80.11 | 3.59 | 17.55 | ₹173 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|
| ₹158 Cr | ₹182 Cr | ₹172 Cr | ₹163 Cr | ₹125 Cr | ₹158 Cr | ₹116 Cr | ₹149 Cr |
| ₹5 Cr | ₹6 Cr | ₹7 Cr | ₹10 Cr | ₹5 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr |
| ₹164 Cr | ₹189 Cr | ₹179 Cr | ₹173 Cr | ₹130 Cr | ₹161 Cr | ₹118 Cr | ₹151 Cr |
| ₹107 Cr | ₹124 Cr | ₹116 Cr | ₹111 Cr | ₹84 Cr | ₹102 Cr | ₹79 Cr | ₹88 Cr |
| ₹60 Cr | ₹69 Cr | ₹67 Cr | ₹66 Cr | ₹49 Cr | ₹63 Cr | ₹42 Cr | ₹65 Cr |
| ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr |
| ₹54 Cr | ₹63 Cr | ₹62 Cr | ₹60 Cr | ₹44 Cr | ₹58 Cr | ₹38 Cr | ₹62 Cr |
| ₹41 Cr | ₹49 Cr | ₹48 Cr | ₹47 Cr | ₹31 Cr | ₹44 Cr | ₹29 Cr | ₹49 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — |
| ₹11 Cr | ₹12 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| ₹872 Cr | ₹481 Cr | ₹355 Cr | ₹222 Cr | ₹162 Cr | ₹113 Cr | ₹80 Cr |
| ₹872 Cr | ₹481 Cr | ₹355 Cr | ₹222 Cr | ₹162 Cr | ₹113 Cr | ₹80 Cr |
| ₹883 Cr | ₹493 Cr | ₹356 Cr | ₹223 Cr | ₹163 Cr | ₹114 Cr | ₹81 Cr |
| ₹15 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹34 Cr | ₹40 Cr | ₹11 Cr | ₹20 Cr | ₹28 Cr | ₹14 Cr | ₹8 Cr |
| ₹9 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| ₹31 Cr | ₹2 Cr | ₹2 Cr | ₹54 L | ₹0 | ₹0 | ₹80,952 |
| ₹4 L | ₹2 Cr | ₹1 Cr | ₹38 L | ₹81 L | ₹1 Cr | ₹94 L |
| ₹74 Cr | ₹49 Cr | ₹20 Cr | ₹25 Cr | ₹33 Cr | ₹19 Cr | ₹13 Cr |
| — | — | — | — | — | — | — |
| ₹68 Cr | ₹60 Cr | ₹51 Cr | ₹38 Cr | ₹27 Cr | ₹18 Cr | ₹9 Cr |
| ₹29 Cr | ₹25 Cr | ₹25 Cr | ₹71 Cr | ₹1 Cr | ₹19 Cr | ₹10 Cr |
| ₹102 Cr | ₹86 Cr | ₹54 Cr | ₹52 Cr | ₹55 Cr | ₹17 Cr | ₹9 Cr |
| ₹2 Cr | ₹4 Cr | ₹7 Cr | ₹10 Cr | ₹63 Cr | ₹27 Cr | ₹9 Cr |
| ₹202 Cr | ₹175 Cr | ₹137 Cr | ₹171 Cr | ₹147 Cr | ₹80 Cr | ₹37 Cr |
| ₹1174 Cr | ₹717 Cr | ₹514 Cr | ₹420 Cr | ₹344 Cr | ₹213 Cr | ₹131 Cr |
| ₹0 | ₹10 L | ₹10 L | ₹10 L | ₹26 L | ₹26 L | ₹0 |
| ₹148 Cr | ₹135 Cr | ₹75 Cr | ₹82 Cr | ₹84 Cr | ₹31 Cr | ₹20 Cr |
| — | — | — | — | — | — | — |
| ₹378 Cr | ₹216 Cr | ₹197 Cr | ₹166 Cr | ₹157 Cr | ₹83 Cr | ₹72 Cr |
| ₹41 Cr | ₹27 Cr | ₹17 Cr | ₹8 Cr | ₹20 Cr | ₹16 Cr | ₹12 Cr |
| ₹337 Cr | ₹189 Cr | ₹180 Cr | ₹158 Cr | ₹137 Cr | ₹68 Cr | ₹60 Cr |
| ₹178 Cr | ₹88 Cr | ₹45 Cr | ₹26 Cr | ₹8 Cr | ₹24 Cr | ₹8 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹19 Cr | ₹6 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹19 Cr | ₹6 Cr |
| ₹13 Cr | ₹15 Cr | ₹13 Cr | ₹5 Cr | ₹2 Cr | ₹2 Cr | ₹79 L |
| ₹15 Cr | ₹33 L | ₹32 L | ₹27 L | ₹0 | ₹0 | ₹0 |
| ₹550 Cr | ₹293 Cr | ₹238 Cr | ₹190 Cr | ₹147 Cr | ₹113 Cr | ₹75 Cr |
| — | — | — | — | — | — | — |
| ₹0 | ₹14 L | ₹13 L | ₹3 Cr | ₹0 | ₹0 | ₹0 |
| ₹216 Cr | ₹129 Cr | ₹67 Cr | ₹71 Cr | ₹37 Cr | ₹17 Cr | ₹9 Cr |
| ₹228 Cr | ₹185 Cr | ₹145 Cr | ₹94 Cr | ₹107 Cr | ₹55 Cr | ₹30 Cr |
| ₹115 Cr | ₹52 Cr | ₹14 Cr | ₹10 Cr | ₹21 Cr | ₹12 Cr | ₹4 Cr |
| ₹10 Cr | ₹19 Cr | ₹6 Cr | ₹4 Cr | ₹50 L | ₹32 L | ₹2 Cr |
| ₹56 Cr | ₹39 Cr | ₹44 Cr | ₹48 Cr | ₹31 Cr | ₹15 Cr | ₹10 Cr |
| ₹624 Cr | ₹424 Cr | ₹275 Cr | ₹230 Cr | ₹197 Cr | ₹99 Cr | ₹56 Cr |
| ₹422 Cr | ₹249 Cr | ₹138 Cr | ₹59 Cr | ₹50 Cr | ₹20 Cr | ₹20 Cr |
| ₹1174 Cr | ₹717 Cr | ₹514 Cr | ₹420 Cr | ₹344 Cr | ₹213 Cr | ₹131 Cr |
| ₹78 | ₹50 | ₹2,527 | ₹1,585 | ₹1,159 | ₹810 | ₹574 |
| ₹78 | ₹50 | ₹37 | ₹23 | ₹17 | ₹12 | ₹8 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| ₹228 Cr | ₹183 Cr | ₹175 Cr | ₹86 Cr | ₹69 Cr | ₹43 Cr | ₹25 Cr |
| ₹9 Cr | ₹15 Cr | ₹13 Cr | ₹18 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr |
| -₹112 Cr | -₹109 Cr | -₹78 Cr | -₹33 Cr | -₹59 Cr | -₹1 Cr | -₹13 Cr |
| ₹125 Cr | ₹89 Cr | ₹110 Cr | ₹71 Cr | ₹15 Cr | ₹46 Cr | ₹16 Cr |
| ₹70 Cr | ₹49 Cr | ₹66 Cr | ₹48 Cr | -₹3 Cr | ₹35 Cr | ₹10 Cr |
| -₹331 Cr | -₹79 Cr | -₹49 Cr | -₹50 Cr | -₹38 Cr | -₹40 Cr | -₹22 Cr |
| ₹247 Cr | ₹53 Cr | -₹13 Cr | -₹10 Cr | ₹51 Cr | ₹13 Cr | ₹12 Cr |
| -₹14 Cr | ₹23 Cr | ₹4 Cr | -₹11 Cr | ₹10 Cr | ₹8 Cr | -₹16 L |
| ₹37 Cr | ₹14 Cr | ₹10 Cr | ₹21 Cr | ₹12 Cr | ₹4 Cr | ₹4 Cr |
| ₹4 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹28 L | ₹16 L | ₹50,000 | ₹23 L | ₹0 | ₹0 | ₹0 |
| ₹27 Cr | ₹37 Cr | ₹14 Cr | ₹10 Cr | ₹21 Cr | ₹12 Cr | ₹4 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found